Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

被引：1
|
作者：
Qin, Hong [1 ]
You, Changqiao [1 ]
Yan, Feng [1 ]
Tan, Kefang [1 ]
Xu, Changgen [1 ]
Zhao, Rui [2 ]
Ekpo, Marlene Davis [2 ]
Tan, Songwen [2 ]
机构：
[1] NanHua Biomed CO Ltd, Res & Dev Dept, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
natural killer (NK) cells; immunosenescence; immunotherapy; cancer; chemotherapy; biotherapeutics; CAR-NK CELLS; CORD BLOOD; ADOPTIVE TRANSFER; CYTOKINE RELEASE; IN-VIVO; IMMUNOTHERAPY; ACTIVATION; EXPANSION; THERAPY; TRANSPLANTATION;
D O I：
10.3389/fonc.2022.1062765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
    Li, Yan-Ruide
    Dunn, Zachary Spencer
    Garcia, Gustavo, Jr.
    Carmona, Camille
    Zhou, Yang
    Lee, Derek
    Yu, Jiaji
    Huang, Jie
    Kim, Jocelyn T.
    Arumugaswami, Vaithilingaraja
    Wang, Pin
    Yang, Lili
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [32] Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
    Zhu, Yanni
    Smith, Drake J.
    Zhou, Yang
    Li, Yan-Ruide
    Yu, Jiaji
    Lee, Derek
    Wang, Yu-Chen
    Di Biase, Stefano
    Wang, Xi
    Hardoy, Christian
    Ku, Josh
    Tsao, Tasha
    Lin, Levina J.
    Pham, Alexander T.
    Moon, Heesung
    McLaughlin, Jami
    Cheng, Donghui
    Hollis, Roger P.
    Campo-Fernandez, Beatriz
    Urbinati, Fabrizia
    Wei, Liu
    Pang, Larry
    Rezek, Valerie
    Berent-Maoz, Beata
    Macabali, Mignonette H.
    Gjertson, David
    Wang, Xiaoyan
    Galic, Zoran
    Kitchen, Scott G.
    An, Dong Sung
    Hu-Lieskovan, Siwen
    Kaplan-Lefko, Paula J.
    De Oliveira, Satiro N.
    Seet, Christopher S.
    Larson, Sarah M.
    Forman, Stephen J.
    Heath, James R.
    Zack, Jerome A.
    Crooks, Gay M.
    Radu, Caius G.
    Ribas, Antoni
    Kohn, Donald B.
    Witte, Owen N.
    Yang, Lili
    CELL STEM CELL, 2019, 25 (04) : 542 - +
  • [33] Multiple levels of chemokine receptor regulation in the control of mouse natural killer cell development
    Bernardini, Giovanni
    Benigni, Giorgio
    Antonangeli, Fabrizio
    Ponzetta, Andrea
    Santoni, Angela
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [34] Murine Schnurri-2 controls natural killer cell function and lymphoma development
    Yamashita, Junji
    Iwamura, Chiaki
    Mitsumori, Kunitoshi
    Hosokawa, Hiroyuki
    Sasaki, Tetsuya
    Takahashi, Munehisa
    Tanaka, Hitoshi
    Kaneko, Kenji
    Hanazawa, Asami
    Watanabe, Yukiko
    Shinoda, Kenta
    Tumes, Damon
    Motohashi, Shinichiro
    Nakayama, Toshinori
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 479 - 486
  • [35] Kctd9 Deficiency Impairs Natural Killer Cell Development and Effector Function
    Zhang, Xiaoping
    Wang, Peng
    Chen, Tao
    Yan, Weiming
    Guan, Xiaoxu
    Shen, Guanxin
    Luo, Xiaoping
    Wan, Xiaoyang
    Ning, Qin
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [36] Challenges of chimeric antigen receptor-T/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies
    Wang, Haifeng
    Pan, Weihuo
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (05) : 967 - 980
  • [37] mTORC1 and mTORC2 differentially promote natural killer cell development
    Yang, Chao
    Tsaih, Shirng-Wern
    Lemke, Angela
    Flister, Michael J.
    Thakar, Monica S.
    Malarkannan, Subramaniam
    ELIFE, 2018, 7
  • [38] SRSF1 plays a critical role in invariant natural killer T cell development and function
    Liu, Jingjing
    You, Menghao
    Yao, Yingpeng
    Ji, Ce
    Wang, Zhao
    Wang, Fang
    Wang, Di
    Qi, Zhihong
    Yu, Guotao
    Sun, Zhen
    Guo, Wenhui
    Liu, Juanjuan
    Li, Shumin
    Jin, Yipeng
    Zhao, Tianyan
    Xue, Hai-Hui
    Xue, Yuanchao
    Yu, Shuyang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (11) : 2502 - 2515
  • [39] Dok1 and Dok2 proteins regulate natural killer cell development and function
    Celis-Gutierrez, Javier
    Boyron, Marilyn
    Walzer, Thierry
    Pandolfi, Pier Paolo
    Jonjic, Stipan
    Olive, Daniel
    Dalod, Marc
    Vivier, Eric
    Nunes, Jacques A.
    EMBO JOURNAL, 2014, 33 (17) : 1928 - 1940
  • [40] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Hadfield, Matthew J.
    Safran, Howard
    Purbhoo, Marco A.
    Grossman, Joseph E.
    Buell, Jennifer S.
    Carneiro, Benedito A.
    ONCOGENE, 2024, 43 (10) : 758 - 762
12345